Diabetic Ulcer Treatment Market Analysis by Ulcer Type (Foot, Mouth, and Other Ulcer); by Treatment Type (Wound-Care Dressings, Wound-Care Devices, Active Therapies, and Others); by End User (Hospitals, Clinics, Ambulatory Surgical Centers, and Homecare) – Global Supply & Demand Analysis & Opportunity Outlook 2023-2033
Buy Now Report ID: 4585 | Published Date: Feb 27, 2023
The global diabetic ulcer treatment market is estimated to garner a revenue of USD 14 Billion by the end of 2033 by growing at a CAGR of ~6% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of USD 8 Billion in the year 2022. A growing number of people being diagnosed with diabetes worldwide is the primary factor for the market's growth. In 2019, diabetes caused 1.5 million deaths directly, with 48% of fatalities occurring before 70 years of age, according to the World Health Organization. The American Diabetes Association reported that nearly 37.3 million Americans, or 11.3% of the population, have diabetes. A total of 28.7 million of them are diagnosed, whilst 8.5 million remain undiagnosed. Diabetes is one of the common diseases that can affect people at a younger age. Moreover, increasing obesity issues, genetics, unhealthy diet habits, and urbanization are some of the reasons for the increase in diabetes risk.
Get more information on this report:Download Sample PDF
The most common type of diabetic ulcer is a foot ulcer which is an open sore or wound and occurs in approximately 15 percent of diabetic patients. A foot ulcer is commonly found on the bottom of the foot. Six percent of those who develop a foot ulcer will require hospitalization for infection or other ulcer-related complications. The treatment for diabetic ulcers involves debriding the wound, treating any infection, revascularizing the area, and off-loading the area. Furthermore, growing awareness of treatment options for diabetic ulcers, improvements in treatment procedures, the approval of new products, and increasing research and development expenditure are projected to drive market growth over the forecast period. According to a recent report by the World Bank, global research and development expenditures are expected to be 2.63 percent of the country's total Gross Domestic Product (GDP) in 2020. The growth is considerably higher than 2.2% in 2018.
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~6% |
|
Base Year Market Size (2022) |
~ USD 8 Billion |
|
Forecast Year Market Size (2033) |
~ USD 14 Billion |
|
Regional Scope |
|
Growth Drivers
Growing Prevalence of Periodontal (Gum) Disease Worldwide - According to the World Health Organization, about 14% of the global adult population suffers from severe periodontal disease, which comprises more than 1 billion cases worldwide. As a result of gum disease, blood sugar levels can increase, which can further exacerbate the problems associated with diabetes, such as heart disease, blood vessel problems, eye problems, kidney problems, and nerve problems. Consequently, poor oral hygiene may contribute to diabetes, which can lead to mouth ulcers. This factor is projected to propel the demand for diabetic ulcer treatment during the forecast period.
Rise in the Number of Inactive Lifestyles that Increases Chances of Obesity and Diabetes - About 60% of U.S. adults do not engage in adequate physical activity, according to the Centers for Disease Control and Prevention. It is estimated that nearly 25 percent of American adults are completely inactive.
Huge Base of Geriatric Population Worldwide Who are More Prone to Diabetes - At the end of 2021, there were 747,238,580 people over 60 years of age living in the world, according to the World Bank. In the future, the number is expected to increase.
Growing Personal Disposable Income Which Changes Lifestyle Habits - According to the Bureau of Economic Analysis, personal income grew by USD 47.0 billion (0.2%) in July 2022, while disposable personal income rose by USD 37.6 billion (0.2%).
Rising Prevalence of Fissured Tongue in Diabetes Owing to Reduced Saliva Flow - For instance, the global prevalence of fissured tongue among diabetic patients is 17% . Diabetes patients showed more of this alteration of 15% than non-diabetics of 11%.
Challenges
The global diabetic ulcer treatment market is segmented and analyzed for demand and supply by ulcer type into foot ulcer, mouth ulcer, and others. Among these segments, the foot ulcer segment is anticipated to capture the largest market size in the global diabetic ulcer treatment market owing to the rapidly growing number of people around the world who are experiencing diabetic foot ulcers (DFUs). A diabetic foot ulcer is a very serious condition in diabetic patients, as the immunity power and wound healing process are compromised in these people. The wound is even prone to get infectious over time if proper medications are not taken. For instance, every year, it is estimated that 9 to 26 million people around the world suffer from diabetic foot ulcers as a result of their diabetes. There is a significant chance that a diabetic foot ulcer will develop over the course of a patient's lifetime in 16 to 24% of patients with diabetes.
The global diabetic ulcer treatment market is also segmented and analyzed for demand and supply by end-user into hospitals, clinics, ambulatory surgical centers, and home care. Amongst these segments, the hospitals segment is expected to garner a significant share. The increasing number of hospitals across the world owing to the increasing number of patients suffering from various diseases, and the growing aging population is estimated to propel the growth of the market segment. The increasing favorable reimbursement policies from the government to support people with low income rises the demand for hospitals. The improvement in treatment methods and the presence of experienced doctors in the hospitals is expected to increase the market segment growth in the forecast period. As per the estimations, there are about 8,200 hospitals in Japan as of 2020 and 4,100 hospitals in Korea.
Our in-depth analysis of the global diabetic ulcer treatment market includes the following segments:
|
By Ulcer Type |
|
|
By Treatment Type |
|
|
By End User |
|
The North America diabetic ulcer treatment market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033. The growth of the market can be attributed majorly to the increasing spending on healthcare along with the presence of key market players in the region. The Centers for Medicare & Medicaid Services has reported that US healthcare spending in 2020 totaled USD 4.1 trillion, which represents 19.7% of the nation’s gross domestic product. Additionally, the increasing adoption of wound care products, coupled with the surging awareness regarding chronic wound care, the rise in technologically advanced research and development activities, and the huge diabetic population in the North America region are expected to fuel the diabetic ulcer treatment market growth in the region during the forecast period. The increasing urbanization and change in lifestyle, which include improper eating habits and a lack of exercise, are estimated to project market growth in the region as these factors increase the risk of diabetes. The rising number of the age-old population who have diabetes and foot ulcer issues are further predicted to boost the market’s growth in the region.
Orpyx Medical Technologies Inc.
Orpyx Medical Technologies Inc., a company specializing in digital health therapeutics, has launched Orpyx SI Sensory Insoles incorporated with remote patient monitoring technology for the prevention of diabetic foot ulcers (DFUs) and ulcers associated with neuropathy.
As part of its therapeutic accessories portfolio, PENTAX Medical has launched a range of platforms dedicated to electrosurgical and argon plasma coagulation (APC) techniques - the ENDO ARC and ENDO PLUS.
In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.
Author Credits: Radhika Gupta, Shivam Bhutani
Ans: Rising Prevalence of diabetes, mouth and foot ulcer, increasing medicare spending along with growing cases of gum diseases are the major factors driving the growth of the diabetic ulcer treatment market.
Ans: The market is anticipated to attain a CAGR of ~6% over the forecast period, i.e., 2023 – 2033.
Ans: Lack of raw materials and supply due to covid-19 and unawareness about the treatment options for diabetic ulcers are the challenges affecting the market growth.
Ans: The market in North America is projected to hold the largest market share by the end of 2033 and provide more business opportunities in the future.
Ans: The major players in the market are Orpyx Medical Technologies Inc., PENTAX Medical, Smith & Nephew plc, Organogenesis Inc., SIGVARIS GROUP, 3M, Molnlycke Health Care AB, Medtronic Plc, Hill-Rom Holdings, Inc., ConvaTec Inc.
Ans: The company profiles are selected based on the revenues generated from the product segment, geographical presence of the company which determine the revenue generating capacity as well as the new products being launched into the market by the company.
Ans: The market is segmented by ulcer type, treatment type, end user and, by region.
Ans: The foot ulcer segment is anticipated to garner the largest market size by the end of 2033 and display significant growth opportunities.
Submit Your Request For Proposal (RFP)
